IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 228 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $471,125 | -10.1% | 103,544 | +39.1% | 0.00% | – |
| Q2 2023 | $524,029 | +24.7% | 74,436 | +8.2% | 0.00% | – |
| Q1 2023 | $420,179 | +8.1% | 68,769 | +13.1% | 0.00% | – |
| Q4 2022 | $388,633 | -13.4% | 60,819 | +29.9% | 0.00% | – |
| Q3 2022 | $449,000 | -15.3% | 46,820 | -2.5% | 0.00% | -100.0% |
| Q2 2022 | $530,000 | +27.4% | 48,014 | +92.1% | 0.00% | – |
| Q1 2022 | $416,000 | +14.3% | 24,996 | +31.1% | 0.00% | – |
| Q4 2021 | $364,000 | -18.6% | 19,067 | +5.3% | 0.00% | – |
| Q3 2021 | $447,000 | +5.7% | 18,109 | +11.5% | 0.00% | – |
| Q2 2021 | $423,000 | +66.5% | 16,244 | +197.2% | 0.00% | – |
| Q4 2020 | $254,000 | +12.4% | 5,465 | -20.4% | 0.00% | – |
| Q3 2020 | $226,000 | -50.5% | 6,869 | -72.6% | 0.00% | -100.0% |
| Q3 2019 | $457,000 | – | 25,097 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 565,890 | $26,257,000 | 9.39% |
| Consonance Capital Management LP | 1,710,803 | $79,381,000 | 7.41% |
| GREAT POINT PARTNERS LLC | 917,427 | $42,569,000 | 6.91% |
| Avoro Capital Advisors LLC | 7,500,000 | $348,000,000 | 5.99% |
| Ghost Tree Capital, LLC | 500,000 | $23,200,000 | 5.17% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $60,923,000 | 4.69% |
| Perceptive Advisors | 9,166,304 | $425,316,000 | 4.56% |
| Ally Bridge Group (NY) LLC | 360,000 | $16,704,000 | 2.86% |
| Orbimed Advisors | 6,645,100 | $308,333,000 | 2.70% |
| ACUTA CAPITAL PARTNERS, LLC | 164,800 | $7,647,000 | 2.08% |